A man in his 60s who developed capillary leak syndrome after receiving the AstraZeneca COVID-19 vaccine has been awarded NT$400,000 (US$12,509) in compensation by the government's Vaccine Injury Compensation Program (VICP).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Heavy rain, cooler weather forecast for Taiwan on Sunday
05/11/2025 11:11 AM - Cross-Strait
Protesters rally in Taipei against documentation rule for Chinese spouses
05/11/2025 10:32 AM - Society
Rally for better child protection draws thousands in Taipei
05/10/2025 10:41 PM - Politics
New pope unlikely to prioritize China-Taiwan-Vatican relations: Scholar
05/10/2025 09:32 PM - Business
China Airlines reports record high Q1 net profit
05/10/2025 09:13 PM